SPIA
ABVX

Steward Partners Investment Advisory’s Abivax ABVX Stock Holding History

Steward Partners Investment Advisory’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.6K Buy
481
+375
+354% +$44.4K ﹤0.01% 2742
2025
Q4 		$14.3K Hold
106
– – ﹤0.01% 3286
2025
Q3 		$9K Buy
+106
New +$6.5K ﹤0.01% 3451

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return

Steward Partners Investment Advisory's ABVX Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its Abivax (ABVX) stake by 354% in Q1 2026, buying an estimated $44.4K and bringing the position to 481 shares worth $53.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2742.

Steward Partners Investment Advisory first reported a position in ABVX in Q3 2025 and has held it in 3 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Steward Partners Investment Advisory held 481 shares of Abivax worth $53.6K as of Q1 2026.
  • Steward Partners Investment Advisory bought 375 Abivax shares in Q1 2026, an estimated $44.4K.
  • Abivax made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #2742 holding.
  • Steward Partners Investment Advisory first reported a position in Abivax in Q3 2025 and has held it in 3 quarters since.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.